About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Compounds Designed Can Treat Glaucoma

by Hannah Joy on November 4, 2017 at 4:25 PM
Font : A-A+

New Compounds Designed Can Treat Glaucoma

Glaucoma is a serious disease, which increases intraocular pressure in the eye and can lead to blindness. New compounds have been designed to reduce intraocular pressure, reveals a new study.

One of the ways to treat glaucoma is to reduce aqueous humour secretion in the ciliary body of the eye by suppressing (inhibiting) activity of special enzymes carbonic anhydrases.

Advertisement


Russian scientists from RUDN University have designed new compounds that can effectively reduce intraocular pressure by isoform selective inhibiting human carbonic anhydrase.

The results of the study were published in the prestigious Bioorganic Chemistry journal.

The study is focused on benzenesulfonamide derivatives containing a 1,2,4-oxadiazole moiety. "It was the first time that these compounds were considered as potential inhibitors of human carbonic anhydrase. Managing the enzyme's activity in ciliary processes using this compounds we can normalize the intraocular pressure," says Anton Shetnev, one of the authors of the paper from RUDN University.
Advertisement

Carbonic anhydrases comprise a family of widespread enzymes that facilitate CO2-bicarbonate interconversion in all tissues of human body. Their function is to catalyze the reversible hydration of carbon dioxide, which produces bicarbonate anion and a proton.

This simple biochemical reaction is central to regulating pH in the intra- and extracellular space in various tissues and organs. It should be noted that carbonic anhydrase in performed by 15 isoforms (isoenzymes) localized in various tissues and slightly differing in the active site architecture.

Sulfonamide-based inhibitors bind to the prosthetic zinc-ion in the catalytic cavity, thussuppressing activity of the enzyme which can be described as a "key-lock" interaction. Most of known carbonic anhydrase inhibitors can be compared to a master key which relatively roughly opens any lock-enzyme (all isoforms)of the corresponding family.

Since the affinity is non-selective (that is, there is no key thread exactly entering the grooves), such an agent might cause plenty of undesired effects. When developing a drug candidate, either potency of selectivity of the inhibitor are crucial.

The latter could be achieved by designing sulfonamide-incorporating small-molecules bearing appropriate molecular periphery.

Our study shows that by attaching substituted oxadiazole ring to the benzenesulfonamide fragment substantional improvement in potency and selectivity of the inhibition can be achieved, thus suggesting this scaffold to be promising for the development of new antiglaucoma drugs.

"We are now to continue improving the selectivity of our inhibitors on the next stages of our work: we need to conduct research aimed at further modification of the compounds in order tomaximize affinity only to the target isoforms, regulating intraocular pressure, which is a great challenge" Anton Shetnev concludes.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Printed Temperature Sensors help with Continuous Temperature Monitoring
Health Benefits of Giloy
Breast Cancer Awareness Month 2021 - It's time to RISE
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Glaucoma Eye Vision Blindness Facts Eye Redness Eye Pain Symptom Evaluation Ocular Hypertension Aniridia Iridectomy 

Recommended Reading
Glaucoma
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ......
Cataract
A cataract is cloudiness in the crystalline lens of the eye that results in a gradually progressive ...
Eye Pain Symptom Evaluation
Eye pain usually follows trauma, eye infection or inflammation of the eye and the surrounding ......
Aniridia
Aniridia is a genetic eye disorder in which the iris is partially or entirely absent. It is associat...
Eye Redness
Redness of the eye occurs due to the dilation of the blood vessels of the eye. It can occur due to e...
Ocular Hypertension
Ocular hypertension is an increase in the intraocular pressure (pressure in the eye) above the upper...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use